These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9283908

  • 21. Myelodysplastic relapse of de novo acute myeloid leukaemia with trilineage myelodysplasia: a previously unrecognized correlation.
    Brito-Babapulle F, Catovsky D, Galton DA.
    Br J Haematol; 1988 Apr; 68(4):411-5. PubMed ID: 3163932
    [Abstract] [Full Text] [Related]

  • 22. Autologous stem cell transplantation in acute myeloid leukemia. Factors influencing outcome. A 13 year single institution experience.
    Martins C, Lacerda JF, Lourenço F, Carmo JA, Lacerda JM.
    Acta Med Port; 2005 Apr; 18(5):329-37. PubMed ID: 16611537
    [Abstract] [Full Text] [Related]

  • 23. Adult de novo acute myeloid leukemia with t(6;11)(q27;q23): results from Cancer and Leukemia Group B Study 8461 and review of the literature.
    Blum W, Mrózek K, Ruppert AS, Carroll AJ, Rao KW, Pettenati MJ, Anastasi J, Larson RA, Bloomfield CD.
    Cancer; 2004 Sep 15; 101(6):1420-7. PubMed ID: 15368330
    [Abstract] [Full Text] [Related]

  • 24. [Prognostic value of early treatment response in children with acute myeloid leukemia].
    Tie LJ, Gu LJ, Song DL, Xue HL, Tang JY, Dong L, Pan C, Chen J, Ye H, Chen J, Wang YP, Zou JY.
    Zhonghua Yi Xue Za Zhi; 2006 Jul 11; 86(26):1837-40. PubMed ID: 17054861
    [Abstract] [Full Text] [Related]

  • 25. De-novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) and myelodysplastic remission marrow (AML/MRM).
    Tamura S, Kanamaru A.
    Leuk Lymphoma; 1995 Jan 11; 16(3-4):263-70. PubMed ID: 7719234
    [Abstract] [Full Text] [Related]

  • 26. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
    Kröger N, Brand R, van Biezen A, Cahn JY, Slavin S, Blaise D, Sierra J, Zander A, Niederwieser D, de Witte T, Myelodysplastic Syndromes Subcommittee of The Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Bone Marrow Transplant; 2006 Jan 11; 37(2):183-9. PubMed ID: 16299545
    [Abstract] [Full Text] [Related]

  • 27. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow.
    Garderet L, Labopin M, Gorin NC, Polge E, Fouillard L, Ehninger GE, Ringden O, Finke J, Tura S, Frassoni F.
    Bone Marrow Transplant; 2003 Jan 11; 31(1):23-9. PubMed ID: 12621503
    [Abstract] [Full Text] [Related]

  • 28. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
    Bloomfield CD, Lawrence D, Byrd JC, Carroll A, Pettenati MJ, Tantravahi R, Patil SR, Davey FR, Berg DT, Schiffer CA, Arthur DC, Mayer RJ.
    Cancer Res; 1998 Sep 15; 58(18):4173-9. PubMed ID: 9751631
    [Abstract] [Full Text] [Related]

  • 29. Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.
    Inaba H, Fan Y, Pounds S, Geiger TL, Rubnitz JE, Ribeiro RC, Pui CH, Razzouk BI.
    Cancer; 2008 Aug 01; 113(3):522-9. PubMed ID: 18484648
    [Abstract] [Full Text] [Related]

  • 30. An antecedent diagnosis of refractory anemia with excess blasts has no influence on mobilization of peripheral blood stem cells and hematopoietic recovery after autologous stem cell transplantation in acute myeloid leukemia.
    Viola A, Falco C, D'Elia R, D'Amico MR, Vicari L, Tambaro FP, Correale P, Laudati D, Palmieri S, Ferrara F.
    Eur J Haematol; 2007 Jan 01; 78(1):41-7. PubMed ID: 17042770
    [Abstract] [Full Text] [Related]

  • 31. Therapy-related acute myeloid leukemia/myelodysplasia with balanced 21q22 translocations.
    Arber DA, Slovak ML, Popplewell L, Bedell V, Ikle D, Rowley JD, International Workshop on Leukemia Karyotype and Prior Therapy.
    Am J Clin Pathol; 2002 Feb 01; 117(2):306-13. PubMed ID: 11863228
    [Abstract] [Full Text] [Related]

  • 32. Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.
    Hofmann WK, Heil G, Zander C, Wiebe S, Ottmann OG, Bergmann L, Hoeffken K, Fischer JT, Knuth A, Kolbe K, Schmoll HJ, Langer W, Westerhausen M, Koelbel CB, Hoelzer D, Ganser A.
    Ann Hematol; 2004 Aug 01; 83(8):498-503. PubMed ID: 15156346
    [Abstract] [Full Text] [Related]

  • 33. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
    Wuchter C, Leonid K, Ruppert V, Schrappe M, Büchner T, Schoch C, Haferlach T, Harbott J, Ratei R, Dörken B, Ludwig WD.
    Haematologica; 2000 Jul 01; 85(7):711-21. PubMed ID: 10897123
    [Abstract] [Full Text] [Related]

  • 34. Poor response to intensive chemotherapy in de novo acute myeloid leukaemia with trilineage myelodysplasia. Japan Adult Leukaemia Study Group (JALSG).
    Kuriyama K, Tomonaga M, Matsuo T, Kobayashi T, Miwa H, Shirakawa S, Tanimoto M, Adachi K, Emi N, Hiraoka A.
    Br J Haematol; 1994 Apr 01; 86(4):767-73. PubMed ID: 7918070
    [Abstract] [Full Text] [Related]

  • 35. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Am J Hematol; 2005 May 01; 79(1):26-35. PubMed ID: 15849776
    [Abstract] [Full Text] [Related]

  • 36. Increased immature hematopoietic progenitor cells CD34+/CD38dim in myelodysplasia.
    Monreal MB, Pardo ML, Pavlovsky MA, Fernandez I, Corrado CS, Giere I, Sapia S, Pavlovsky S.
    Cytometry B Clin Cytom; 2006 Mar 01; 70(2):63-70. PubMed ID: 16470534
    [Abstract] [Full Text] [Related]

  • 37. [Clinical analysis of HLA-DR-negative non-M3 AML].
    Mori H, Sakai H, Sanada M, Shimamoto K, Sasaki S, Azuma R, Higuchi T, Harada H, Niikura H, Omine M, Fujita K, Takahashi N.
    Rinsho Ketsueki; 2007 Jul 01; 48(7):547-53. PubMed ID: 17695303
    [Abstract] [Full Text] [Related]

  • 38. Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia.
    Tsimberidou AM, Stavroyianni N, Viniou N, Papaioannou M, Tiniakou M, Marinakis T, Skandali A, Sakellari I, Yataganas X, Hellenic Cooperative Group.
    Cancer; 2003 Apr 01; 97(7):1721-31. PubMed ID: 12655529
    [Abstract] [Full Text] [Related]

  • 39. The natural history of trilinear myelodysplastic syndrome and erythroleukemia.
    Michiels JJ, van der Meulen J, Brederoo P.
    Haematologica; 1997 Apr 01; 82(4):452-54. PubMed ID: 9299860
    [Abstract] [Full Text] [Related]

  • 40. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Runde V, de Witte T, Arnold R, Gratwohl A, Hermans J, van Biezen A, Niederwieser D, Labopin M, Walter-Noel MP, Bacigalupo A, Jacobsen N, Ljungman P, Carreras E, Kolb HJ, Aul C, Apperley J.
    Bone Marrow Transplant; 1998 Feb 01; 21(3):255-61. PubMed ID: 9489648
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.